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ARTICLE
Pulmonary toxicity of inhaled nano-sized cerium oxide aerosols
in Sprague–Dawley rats
Chang Guoa, Sarah Robertsona, Ralf J. M. Weberb, Alison Buckleya, James Warrena, Alan Hodgsona,
Joshua Z. Rappoportc, Konstantin Ignatyevd, Kirsty Meldruma, Isabella R€omera, Sameirah Macchiaruloa,
James Kevin Chipmanb, Tim Marczyloa, Martin O. Leonarda, Timothy W. Ganta, Mark R. Viantb and
Rachel Smitha
aCentre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Science and Innovation Campus, Didcot,
Oxfordshire, OX11 0RQ, UK; bSchool of Biosciences, University of Birmingham, Birmingham, B15 2TT, UK; cDepartment of Cell and
Molecular Biology, Northwestern University, Chicago, IL, USA; dDiamond Light Source Ltd, Harwell Science and Innovation Campus,
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ABSTRACT
Cerium oxide nanoparticles (CeO2NPs), used in some diesel fuel additives to improve fuel combus-
tion efficiency and exhaust filter operation, have been detected in ambient air and concerns have
been raised about their potential human health impact. The majority of CeO2NP inhalation studies
undertaken to date have used aerosol particles of larger sizes than the evidence suggests are
emitted from vehicles using such fuel additives. Hence, the objective of this study was to investi-
gate the effects of inhaled CeO2NP aerosols of a more environmentally relevant size, utilizing a
combination of methods, including untargeted multi-omics to enable the broadest possible survey
of molecular responses and synchrotron X-ray spectroscopy to investigate cerium speciation. Male
Sprague–Dawley rats were exposed by nose-only inhalation to aerosolized CeO2NPs (mass concen-
tration 1.8mg/m3, aerosol count median diameter 40nm) for 3h/d for 4 d/week, for 1 or 2 weeks
and sacrificed at 3 and 7d post-exposure. Markers of inflammation changed significantly in a
dose- and time-dependent manner, which, combined with results from lung histopathology and
gene expression analyses suggest an inflammatory response greater than that seen in studies
using micron-sized ceria aerosols. Lipidomics of lung tissue revealed changes to minor lipid spe-
cies, implying specific rather than general cellular effects. Cerium speciation analysis indicated a
change in Ce3þ/Ce4þ ratio within lung tissue. Collectively, these results in conjunction with earlier
studies emphasize the importance of aerosol particle size on toxicity determination. Furthermore,
the limited effect resolution within 7d suggested the possibility of longer-term effects.
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Introduction
Nanomaterials offer unique mechanical, chemical,
electrical and optical properties that are being
exploited for an extensive range of applications;
however, concerns remain about their potential
impact on human health. Cerium oxide nanopar-
ticles (CeO2NPs) are one of the manufactured nano-
materials currently receiving significant attention
with respect to their potential health risks as they
are used in a range of applications with the
potential for direct human exposure, including pol-
ishing media (Reed et al. 2014) and fuel-borne cata-
lysts, such as EolysTM, Platinum PlusTM, and
EnviroxTM (Majestic et al. 2010). The benefits of
CeO2NP-based fuel additives include reduced emis-
sions of gaseous products of incomplete combus-
tion and improved fuel combustion efficiency
(Zhang et al. 2013). However, CeO2NPs have been
detected in ambient air in locations where such
additives are in use (Park et al. 2008a, Gantt et al.
2015) and there are concerns about their potential
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impact on health following inhalation (Geraets
et al. 2012).
Reported effects of CeO2NPs in vivo following
intratracheal instillation include alveolar epithelial
hyperplasia, lung inflammation, air-blood barrier
damage, and fibrosis of the lungs (Ma et al. 2011;
Ma et al. 2012; Peng et al. 2014; Rice et al. 2015). A
number of in vivo inhalation studies have also
reported similar effects, with indications that pul-
monary inflammatory responses are slow to resolve
post-exposure (Aalapati et al. 2014). Inhalation bio-
distribution studies have also found significant
accumulation in pulmonary tissue and slow clear-
ance (Geraets et al. 2012; Li et al. 2016).
Field studies have identified ceria particles emit-
ted from vehicles using the EnviroxTM fuel additive,
with a size range from 5 to 100 nm (Gantt et al.
2014). However, to date, the majority of reported
CeO2NP inhalation studies, as summarized in Table
1, including those mentioned above, have used
aerosols in the micron-size range or at the upper
end of the nano-size range and therefore, given the
importance of particle size in driving biological
effects (Oberd€orster, Ferin, & Lehnert 1994;
Braakhuis et al. 2016), may not be directly relevant
to a hazard assessment of the effect of ceria par-
ticles emitted from engines using CeO2NP fuel addi-
tives. The purpose of this study was, therefore, to
undertake a short-term in vivo inhalation study
using a ceria aerosol with a more environmentally
relevant aerosol particle size, to investigate the
effects on lung inflammation and injury. It was
anticipated that comparing the results of this study
with those in the literature, which have all used sig-
nificantly larger aerosol particle sizes, would provide
support for the hypothesis that aerosol particle size
is an important toxicity driver.
We also utilized a multi-omics approach – apply-
ing microarray-based gene expression profiling and
untargeted mass spectrometry-based lipidomics –
to enable a broad measurement of thousands of
molecular endpoints to provide insights into the
toxicity mechanisms of CeO2NPs (Taylor et al. 2016;
Dekkers et al. 2018). Furthermore, we assessed the
distribution of inhaled CeO2NPs in various organs
and their physicochemical properties using a range
of approaches. Many studies have indicated that
the physicochemical properties of nanomaterials
have a significant influence on their biological
activity. CeO2NPs are an interesting case as it has
been hypothesized that initial differences in the
Ce3þ/Ce4þ ratio on the NP surface, and changes in
their anti-oxidant potential following exposure, may
play a significant role in toxicity determination
(Auffan et al. 2009). To explore this, synchrotron-
based spectroscopy was applied to determine cer-
ium oxidation states in exposed lung tissues.
Materials and methods
Cerium oxide nanoparticles
CeO2NPs (primary particle size 8 nm) were provided
by the University of Birmingham. Details of the syn-
thesis are described in the Supplementary informa-
tion (Chen et al. 2013). The powder was dispersed
in MilliQ water (1mg/mL) and sonicated briefly
( 1min) prior to use.
Exposure system and aerosol characterization
The nose-only inhalation exposure system and the
aerosol characterization undertaken are described in
the Supplementary information. Details of the dose
estimation method are also described in the
Supplementary information.
Study design
The experiments were performed within the legal
framework of the United Kingdom under a Project
License granted by the Home Office of Her
Majesty’s Government. All procedures involving the
animals were performed in accordance with the
Animals (Scientific Procedures) Act 1986. Male
Sprague–Dawley (SD) rats (10–12weeks, 250–320 g)
were purchased from Harlan, UK. Rats were ran-
domly assigned into groups and exposed to aero-
solized CeO2NPs or water (controls) for 3 h per day,
for 4 d per week, for 1 or 2 weeks. The 2-week
exposure was chosen to explore the effect of a
higher deposited dose within the lung, an alterna-
tive approach of using a higher aerosol concentra-
tion was discounted as this would have affected
the aerosol particle size. Following exposure, the
rats were returned to their cages for a period of
either 3 d, to characterize the initial response, or 7 d
to explore recovery and other effects in the short-
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term. Assessment of adverse clinical signs is
described in the Supplementary information.
Analysis of bronchoalveolar lavage fluid (BALF)
Rats were sacrificed by exsanguination by cardiac
puncture under isoflurane anesthesia (induced at
5%, maintained at 1.5–2% in 100% oxygen).
Bronchoalveolar lavage was performed in situ via
tracheal cannula with 2 7mL aliquots of phos-
phate buffered saline (PBS). Cells from both aliquots
were pooled for cytological analysis as described in
the Supplementary information. BALF supernatants
from the first wash were collected for analysis of
cytotoxicity and alveolar barrier damage as
described in the Supplementary information.
Cytokines and chemokines including IL-1b (inter-
leukin-1b), TNF-a (tumor necrosis factor-a), TFG-b1
(transforming growth factor-b1), CXCL2 (CINC-3,
cytokine-induced neutrophil chemoattractant 3),
CXCL1 (CINC-1, cytokine-induced neutrophil chemo-
attractant 1), and CCL2 (MCP-1, monocyte chemo-
attractant protein-1) were measured in BALF
supernatants using R&D Systems QuantikineVR ELISA
kits according to the manufacturer’s specifications.
Lung tissue processing
Following lavage, the apical and azygous lung lobes
were tied off and snap frozen in liquid nitrogen for
multi-omics analysis. The remainder of the lungs was
removed and inflated and fixed with freshly made 4%
paraformaldehyde via tracheal cannula, at a pressure
of 30 cm of water and then processed into paraffin
blocks. Cross/transverse sections of lung tissues
chosen randomly were cut at a thickness of 5lm
before mounting onto microscope slices. For histo-
pathology, staining with hematoxylin and eosin (H&E)
was performed on lung tissue sections.
Multi-omics analysis of lung
Lung tissues were homogenized in 8mL/g (v/w wet
mass) methanol and 2.5mL/g (v/w) water using a
bead-based homogenizer (Precellys 24; Stretton
Scientific, Stretton, UK). Lung homogenate aliquots
were then taken for both metabolite and RNA
extractions. Total RNA was isolated using Qiagen’s
mini RNeasy Kit and QIAshredder (Qiagen, Crawley,
UK) according to the manufacturer’s protocol. RNA
was quantified with a NanoDrop 1000 spectropho-
tometer (Thermo Scientific, Waltham, MA), and the
integrity of RNA was verified with a 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Lipids from the lung homogenate were extracted
using a methanol:water:chloroform (2:2:1.8) solvent
system (Wu et al. 2008), dried using a centrifugal
concentrator and stored at –80 C until analysis.
Microarray-based gene expression profiling was
performed according to the manufacturer’s protocol
(Agilent Technologies, Santa Clara, CA). Further
details are described in the Supplementary informa-
tion. Mass spectrometry-based lipidomics was per-
formed using a high-resolution spectral-stitching
nanoelectrospray direct-infusion approach as previ-
ously reported (Southam et al. 2017). Further details
are described in the Supplementary information.
Cerium in tissues determined by ICP-MS and laser
ablation ICP-MS
The cerium content of liver and kidney samples was
determined using inductively coupled plasma mass
spectrometry (ICP-MS) as described in the
Supplementary information. Elemental mapping of cer-
ium in lung tissue samples was undertaken by laser
ablation ICP-MS using a New Wave Research NWR213
laser ablation system (Electro Scientific Industries,
Portland, OOR) linked to an iCAP Q ICPMS (Thermo
Fisher Scientific, Hemel Hempstead, UK). Further details
are described in the Supplementary information.
Transmission electron microscopy (TEM)
Lung tissues from animals at 3 d after 2-week
exposure (CeO2NP exposed and control) were pre-
pared as described in the Supplementary informa-
tion and TEM imaging was then performed using
an FEI Tecnai Spirit G2.
Synchrotron-based X-ray spectroscopy
Synchrotron microfocus X-ray spectroscopy was car-
ried out at the Diamond Light Source I18 Beamline
(Oxfordshire, UK). Microfocus X-ray fluorescence
(l-XRF) analysis was undertaken to provide informa-
tion on the spatial distribution of elements of inter-
est for a number of lung sections. For identified
areas of high cerium concentration, X-ray
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absorption near-edge structure (XANES) spectrom-
etry of the Ce LIII-edge was carried out to investi-
gate chemical speciation (e.g. oxidation state). The
spectra produced were compared with those for
samples of some cerium compounds: Ce2(CO3)3,
Ce(OH)4 (Sigma-Aldrich, St. Louis, MO), and CeO2
(Acros Organics, Morris, NJ), and a sample of the
CeO2NPs. Further details are described in the
Supplementary information.
Results
Aerosol characterization
Aerosol characteristics and lung dose estimates are
presented in Table 2 and Figure 1, including repre-
sentative images of agglomerated CeO2NP aerosol
particles, illustrating their spherical form and pri-
mary particle size consistent with the manufac-
turer’s data (ca 8 nm) (Chen et al. 2013).
Figure 1. (A) CeO2NP aerosol particle size distribution. (B–D) Transmission electron microscope images of CeO2NP aerosol particles
illustrating clear crystalline form (D).
Figure 2. Comparison of changes in BALF parameters after 1 week (A) and 2 weeks (B) of exposure to CeO2NP aerosols. Changes
are shown as fold differences compared to controls (H2O aerosols) using logarithmic scaling (MPH: macrophages; PMN: neutro-
phils; LYMPH: lymphocytes; LDH: lactate dehydrogenase; ALP: alkaline phosphatase).
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Acute pulmonary toxicity effects induced by
inhaled CeO2NPs
Inhalation exposure to CeO2NPs did not affect the
body weight development of the rats (data not
shown). No adverse clinical signs were observed in
any of the animals.
Cytology and cytotoxicity analysis of bronchoalveo-
lar lavage fluid (BALF)
BALF analysis was undertaken at 3 d and 7d post-
exposure for both 1-week and 2-week exposure
groups. The majority of BALF parameters showed sig-
nificant increases for CeO2NP exposed groups com-
pared to the control groups (Figure 2, with details
presented in Supplementary Figures S2 and S3). For
the 1-week exposure group, there was a small but sig-
nificant increase in the different cell populations
between 3 and 7d post-exposure, although the levels
of total protein, lactate dehydrogenase (LDH) and
alkaline phosphatase (ALP) showed a reduction over
this period indicating limited recovery. For the 2-week
exposure group, there was no significant change in
the total protein, LDH or ALP levels between 3 and 7d
post-exposure, but significant increases in the differ-
ent cell populations. The above indicates that the
inhaled CeO2NPs induced time- and dose-dependent
inflammation and lung damage.
Cytokines/chemokines in BALF
Effects on several cytokines and chemokines relevant
to inflammatory responses and allergic effects were
considered. There was no significant change in IL-1b
concentrations for any exposed group (Figure 3(A)),
whereas for TNF-a and TFG-b1 there were significant
increases in some groups (Figure 3(B,C)). For CXCL2,
CXCL1, and CCL2, there were significant increases for
all exposed groups (Figure 3(D–F)). The effects were
the greatest for CXCL1 and CCL2, for which there was
a clear dose-dependent effect at both post-exposure
times. There was also some indication of
Figure 3. Cytokine levels in BALF from rats exposed to H2O or CeO2NP aerosols. (A) IL-1b, (B) TNF-a, (C) TFG-b1, (D) CXCL2/CINC-
3, (E) CXCL1/CINC-1, and (F) CCL2/MCP-1. Data shown as mean± SD (n¼ 5 rats for groups exposed to CeO2NP aerosols and n¼ 3
for control groups exposed to H2O aerosols).  p< 0.05,  p< 0.01,  p< 0.001.
NANOTOXICOLOGY 737
concentrations increasing with time post inhalation,
although this was only significant for CCL2 for the 1-
week exposure. For the others, patterns were less
clear, with CXCL2 showing no dose- or time-depend-
ence, TGF- b1 showing no time-dependence and
dose-dependence for the 7-d groups only, and TNF-a
Figure 4. Representative hematoxylin and eosin stained lung sections (200, inset 400) from rats of negative controls (A and B) and
CeO2NP aerosol exposure at 3 d (C and D) and 7d (E and F) post-exposure (A, C, E, 1-week exposure; B, D, F, 2-week exposure). Symbols
indicate some histopathological observations including infiltration of inflammatory cells (black arrows), deposition of amorphous eosino-
philic materials (diamond arrows), alveolar wall injury (open arrows) and minor alveolar epithelial hyperplasia (areas inside black circles).
Figure 5. Principal component analysis (PCA) score plots of the gene expression (A) and lipidomics profiles (B) of lung tissue
from rats exposed to H2O and CeO2NP aerosols for 1 week and 2 weeks at 3 d post-exposure.
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Figure 6. Representative laser ablation inductively coupled plasma mass spectrometry elemental maps (isotopes 13C and 140Ce)
and light microscopy images (12.5) of lung tissues of negative controls (images A–C) and CeO2NP aerosol exposed animals at
3 days (images D–F) and 7 d (images G–I) post-exposure. The light microscope images show the lung tissue section prior to under-
taking laser ablation (which destroys the sample) and allow the overall shape and structures such as large airways and larger
blood vessels to be seen for comparison purposes.
Figure 7. Transmission electron microscope images of lung tissue from rats exposed to H2O aerosols (A) and CeO2NP aerosols (B)
for 2 weeks at 3 d post-exposure. The boxes with dotted lines denote the approximate locations of the corresponding magni-
fied regions.
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showing dose-dependence for the 3-d groups only
and time-dependence for the 1-week exposure groups
only.
Histopathology – lung inflammatory changes
Inhalation of CeO2NPs resulted in mild inflammation
for both exposure durations and at both 3 and 7 d
post-exposure (Figure 4). The lung architecture was
well preserved with inhaled CeO2NPs but minor
alveolar epithelial hyperplasia with accumulation of
eosinophilic materials from macrophage breakdown
was observed. The lung injury induced by CeO2NPs
appeared to increase with time for 1-week exposure
based on the histopathological observations.
Multi-omics analysis of lung
Principal component analysis (PCA) score plots from
the analysis of the gene expression and lipidomics
measurements are shown in Figure 5. For the gene
expression analysis, the score plot captured 53.6%
of the variation in the dataset within the first two
components; a significant separation between rats
exposed to H2O aerosols and CeO2NP aerosols was
discovered along PC1 (t-test of the scores values:
p¼ 4.0 103, Figure 5(A)), confirming that the NP
exposure induced perturbations to gene transcrip-
tion. The PCA score plot derived from the lipido-
mics data captured 55.6% of the variation in the
first two components, and also showed a significant
separation between control and CeO2NP aerosols,
in this case along PC2 (t-test of the scores values:
p¼ 8.5 104, Figure 5(B)). Limma was applied to
the gene expression data to investigate the effects
of CeO2NP exposure (H2O aerosol exposure as the
controls) and it was found to be statistically signifi-
cant with CeO2NP exposure (q< 0.05 and log2-fold
change >1.0) for 67 genes (Supplementary Table
S1). DAVID analysis on the 67 differentially
expressed genes (of which 53 were matched to a
gene present in DAVID) yielded 13 GO-categories
that were significantly enriched (q< 0.05,
Supplementary Table S2).
For the lipidomics data, two-way ANOVA (type II,
unbalanced) was conducted on each peak to investi-
gate the effects of inhaled CeO2NPs and exposure
dose (1-week versus 2-week exposure). CeO2NP
inhalation was statistically significant for 38 peaks
(q< 0.05) of which 19 where putatively annotated
with a lipid name from the Lipid Maps database
(Supplementary Table S3 and Supplementary File
SI1). Exposure dose had no significant effect on any
of the peak intensities. Enrichment analysis of cat-
egorical annotations of the significant and annotated
lipids was conducted, using MBROLE (Lopez-Ibanez,
Pazos, & Chagoyen 2016) (Supplementary Table S4)
and LIPID Metabolites And Pathways Strategy (LIPID
Figure 8. (A) XANES Ce LIII spectra for cerium standard sam-
ples of Ce2(CO3)3, Ce(OH)4, and CeO2. (B–C) XANES Ce LIII spec-
tra derived from cerium-rich pixels of elemental m-XRF maps
of lung tissue sections from rats exposed to the CeO2NP aero-
sols for two weeks at 3 d (B, A combination of 4 pixels) and
7 d (C, A combination of 6 pixels) post-exposure. The top
right-hand corner images in B and C are the associated elem-
ental m-XRF maps of cerium in lung tissue samples from ani-
mals post-exposure. Data obtained using the I18 beamline at
the Diamond Light Source (pixel size 4mm  4mm).
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MAPSVR ), and revealed that several lipid classes (e.g.
glycerophospholipids) and subclasses (e.g. diacylgly-
cerophosphocholines, glycerophosphoethanolamines,
and diacylglycerophosphoethanolamines) were sig-
nificantly enriched.
Assessment of the inhaled CeO2NPs
Detection of CeO2NPs deposited in the lung
Elemental maps of lung tissues produced by laser
ablation ICP-MS clearly indicate the presence of cer-
ium, widely distributed within the lung lobes, with-
out any significant association with the larger
airways or larger blood vessels (Figure 6). TEM
micrographs (Figure 7) indicate the presence of
dense particle agglomerates of similar size to the
CeO2NP aerosol agglomerates in the alveolar mac-
rophages, mainly in the lysosome-like intracellu-
lar vesicles.
Cerium in liver and kidney
The concentrations of cerium in the liver and kid-
ney were measured by ICP-MS and were greater in
exposed than control animals, higher for 2-week
than 1-week exposure, and increased from 3d to
7 d post-exposure, indicating the translocation of
cerium from the lung to other organs after inhal-
ation, however, these changes were only statistically
significant for some groups (Supplementary
Figure S5).
Cerium speciation by synchrotron X-ray spectroscopy
Cerium LIII XANES spectra of the cerium compounds
Ce2(CO3)3, CeO2, and Ce(OH)4 are shown in Figure
8(a). Both Ce4þ compounds (CeO2, and Ce(OH)4)
show a doublet peak of roughly equal height,
whereas the Ce3þ carbonate (Ce2(CO3)3) shows a
clearly different peak morphology. The XANES spec-
trum for the CeO2NP sample appears qualitatively
similar to the Ce4þ compounds (Supplementary
Figure S6). A linear combination fitting (LCF) ana-
lysis was carried out for the CeO2NP spectrum using
the spectra from the cerium compounds as stand-
ards. The fit analysis indicated that the CeO2NP
sample was 100% CeO2 with zero contributions
from the other standards.
Cerium mapping of lung tissue sections from
exposed rats was undertaken using l-XRF, and
XANES spectra collected from identified areas of
high cerium concentration (Figure 8(B,C)).
Quantitative LCF analysis was carried out in each
case, using the standards’ spectra. The results indi-
cated 21% Ce3þ carbonate and 79% Ce4þ oxide at
3 d and 15% Ce3þ carbonate and 85% Ce4þ oxide
at 7 d post-exposure. In comparison to the 100%
Ce4þ in the aerosol NPs, these results indicate
changes to cerium speciation in the lung following
inhalation; however, given the limited sample num-
bers, it is not possible to judge whether the differ-
ence between 3 and 7 d is significant.
Discussion
We have investigated the pulmonary toxicity of
nano-sized CeO2NP aerosol agglomerate particles
(CMD approximately 40 nm, GSD 1.7; primary par-
ticle size 5–10 nm). Histopathology indicated mild
inflammation with alveolar epithelial hyperplasia
(Figure 4), which increased with time after expos-
ure, suggesting the potential for long-term effects.
Consistent with this the BALF analysis indicates a
significant inflammatory response increasing
between 3 and 7 d (Figure 2 and Supplementary
Figure S2 and S3). These changes were matched by
significant increases in cytokines involved in inflam-
matory cell infiltration, such as CXCL1(CINC-1) and
CCL2(MCP-1) (Figure 3), with levels increasing with
dose for each post inhalation time (dose-depend-
ence). Concentrations of total protein, LDH, and
ALP in BALF increased significantly for all groups
exposed to CeO2NP aerosols (Figure 2 and
Supplementary Figure S3) with some evidence of
recovery only for the 1-week exposures, again sug-
gesting the potential for longer-term effects. The
gene expression results (Supplementary Table S2)
are consistent with the above, with significant Gene
Ontology terms including (GO:0030593) neutrophil
chemotaxis, (GO:0048247) lymphocyte chemotaxis,
(GO:0008009) chemokine activity, and (GO:0002548)
monocyte chemotaxis.
Other CeO2NP inhalation studies have also shown
lung inflammation, cytotoxicity, and air-blood barrier
damage;, however, the majority of such studies have
used aerosols with micron-sized aerosol
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agglomerates (Table 1), significantly larger than used
in this study, and the resulting effects are typically
less marked than indicated here. To achieve similar
or relatively comparable toxicological effects, inhal-
ation studies with micron-sized CeO2NP aerosols usu-
ally used higher aerosol concentrations or longer
exposure durations (Table 1). Landsiedel et al. (2014),
for example, used a similar short-term repeated
exposure study design (6h/d for 5 d with sacrifice at
3 d) with a micron-sized aerosol, which at the low con-
centration (0.8mg/m3) delivered a very similar
‘exposure dose’ (i.e. concentration duration) to our
one week exposure, and yet their results at this con-
centration indicate a significantly lower response, with
small but significant changes for only three endpoints,
including neutrophil and lymphocyte number but not
LDH. Only at the medium and high concentrations,
delivering exposure doses >4 times higher, were sig-
nificant changes seen, similar to those here. Keller
et al. (2014) also used a micron-sized aerosol in a
short-term repeated dose study using three concen-
trations, the lowest of which delivered a similar expos-
ure dose to our 1-week study. However, it was only at
the medium and high concentrations, delivering
exposure doses >5 times higher than our study, that a
broad pattern of changes was seen, similar to the
results presented here. It is clearly more difficult to
make direct comparisons with the results from studies
with longer exposure durations; however, it is instruct-
ive to note that levels of CCL2(MCP-1), which were sig-
nificantly enhanced in this study, were only
significantly enhanced in a 28-d study (6h/d, 5 d/
week, 4weeks) (Schwotzer et al. 2017, 2018) at the
two highest concentration levels, which would have
resulted in exposure doses >3 times higher than this
study, and for neutrophil numbers and LDH levels
only the highest concentration (3mg/m3), delivering
an exposure dose 9 times greater, produced similar
effects to those reported here. Schwotzer et al. (2018)
also assessed the effect of exposure on the expression
of 391 genes in alveolar epithelial type II cells and
identified significant regulatory changes to a total of
30 genes, many of which (e.g. inflammatory cytokines:
CCL2, CCL22, CCL7, and CCL17; markers of lung
cancer: Mmp12, indicators of oxidative stress: Fabp4
and Noxo1) were also identified in this study, but
again significant changes to gene regulation were
only seen at exposure doses markedly higher than
used here.
The above comparison supports a conclusion that
nano-sized aerosols of CeO2NPs are more effective
than micron-sized at generating effects. A few other
in vivo inhalation studies have used nano-sized
CeO2NPs aerosols, albeit with larger aerosols than
used here (40 nm). For example, Demokritou et al.
(2013) used a 90 nm aerosol and a similar study
design (2.7mg/m3  2 h/d 4 d), resulting in a very
similar exposure dose which generated significant
neutrophilia and cell damage (LDH), similar to this
study. Comparing the two studies, it is possible to
argue that the levels of PMN infiltration and LDH are
higher in the current study suggesting greater effects
for the smaller aerosol; however, this may be a result
of other factors including differences in the sacrifice
time post-exposure (1 d versus 3 d). Morimoto et al.
(2015) used an approximately nano-sized
(90–110 nm) aerosol in a 28-d study (2 and 10mg/
m3) and found a pattern and degree of inflammatory
effects at 3 and 7d post-exposure similar to the cur-
rent study despite significantly greater levels of
exposure, again suggesting a greater effect for the
smaller aerosol particles. It is also interesting to note
that Morimoto et al (2015) saw a reduction in effects
between 3 and 7 d for some endpoints, which was
not seen for our 2-week exposure. The results of our
study are, therefore, broadly consistent with the
small number of studies using nano-sized aerosols,
but suggestive of a greater biological potency for our
smaller aerosol.
It is generally understood that aerosol particle
size influences the resulting biological effects fol-
lowing inhalation for a number of related reasons:
level and pattern of deposition within the lung
depends in detail on the aerosol particle size distri-
bution in a non-linear manner, but with aerosol par-
ticles below 100 nm (peak around 20 nm) generally
depositing more efficiently in the alveolar region
than larger particles (Asgharian et al. 2009); smaller
Table 2. Summary of aerosol characteristics and deposited dose estimates.
Exposure group CMD (nm) GSD Number conc. (particles/cm3) Mass conc. (mg/m3) Dose (lung) (mg) Dose (alveolar) (mg)
1-week exposure (3 h/d, 4 d/week) 43.4 1.70 2.16 106 1.80 79 49
2-week exposure (3 h/d, 4 d/week) 43.8 1.72 1.96 106 1.82 161 100
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particles may also be less efficiently phagocytosed
and, therefore, cleared from the lung than larger
particles, thus leading potentially to prolonged
exposure and build-up; and smaller particle size
also implies a greater surface area per unit depos-
ited mass, which a number of in vitro and in vivo
studies have linked to greater toxicity (e.g.
Oberd€orster et al. 2005; Stoeger et al. 2006). All
these factors may have contributed to the greater
apparent short-term toxicity of the aerosols used in
this study in comparison with others in
the literature.
A generally accepted paradigm is that the tox-
icity of nanomaterials arises primarily as a result of
their ability to generate reactive oxygen species
(ROS) and thus oxidative stress damage (Fu et al.
2014). Studies have demonstrated that CeO2NPs
can induce oxidative stress and resulting toxicity in
vivo (Nemmar et al. 2017) and in vitro (Park et al.
2008b; Eom and Choi 2009). The hierarchical model
of oxidative stress (Damoiseaux et al. 2011) pro-
poses that cells and tissues respond to increasing
levels of NP-induced oxidative stress via various
enzyme systems - mild oxidative stress results in
transcriptional activation of phase II antioxidant
enzymes via nuclear factor (erythroid-derived 2)-like
(Nrf2) induction; and at an intermediate level,
redox-sensitive mitogen-activated protein kinase
(MAPK) (family includes p38 MAPK and growth fac-
tor-regulated extracellular signal-related kinases
(ERK)) and nuclear factor kappa-light-chain enhancer
of activated B cells (NF-kappaB) cascades mount a
pro-inflammatory response. Compatible with this
hypothesis, in vitro studies have shown that
CeO2NPs induce toxicity in human bronchial epithe-
lial cells via oxidative stress and the p38-Nrf2 signal-
ing pathway (Eom & Choi 2009) and in human
hepatoma cells via oxidative stress and the activa-
tion of MAPK signaling pathways (Cheng et al.
2013). One of the significantly enriched terms in the
Gene Ontology analysis of the 67 differentially
expressed genes in this study (Supplementary Table
S2) was GO:0070374 – positive regulation of ERK1
and ERK2 cascade, which is also consistent with the
above model. MAPK pathways have also been
shown to mediate toxicity for other nanomaterials,
e.g. titanium dioxide (Park et al. 2008c) and other
inhaled pollutants, e.g. cadmium (Cormet-Boyaka
et al. 2012).
Cerium speciation
Cerium can exist in both 3þ and 4þ oxidation
states. Typically the cerium in CeO2NPs is predomin-
antly Ce4þ, however, surface defects mean that
Ce3þ is also found at the surface, and indeed for
CeO2NPs (3–30 nm) the majority of the surface ceria
is Ce3þ (Deshpande et al. 2005). It has been
hypothesized that initial differences in the Ce3þ/
Ce4þ ratio on the NP surface and changes to this
following exposure may play a significant role in
toxicity determination (Auffan et al. 2009). In our
study, to our knowledge the first to investigate cer-
ium speciation in rat lung after inhalation exposure
to CeO2NPs, analysis of the XANES cerium spectra
(Figure 7) indicates that the cerium in the nanopar-
ticles was largely Ce4þ; however, the cerium in the
tissue samples was 15–21% Ce3þ, indicating a
change in speciation following delivery to the lung.
This speciation change is consistent with in vitro
studies, which have indicated higher Ce3þ speci-
ation inside rather than outside cells (Szymanski
et al. 2015). Some studies have found that the pres-
ence of phosphate ions in aqueous systems signifi-
cantly affects the reactivity of ceria and it has been
hypothesized that the formation of cerium phos-
phate in biological systems would ‘trap’ cerium in
the 3þ state and thus block potential cycling
between Ce3þ and Ce4þ (Singh et al. 2011). Further
studies are required to investigate the potential
links between speciation and toxicity mechanisms,
especially for long-term pulmonary effects, which,
given the ability of CeO2NPs to generate ROS in a
number of in vitro and in vivo systems (Lin et al.
2006; Park et al. 2008b; Nemmar et al. 2017) may
relate to ROS generation capacity.
Lipidomic analysis
The most abundant lipid classes in the lung lipi-
dome are glycerophosphocholines (PC), due to their
significant role in lung surfactant, glycerophosphoe-
thanolamines (PE), glycerophosphoserines (PS), glyc-
erolphosphoglycerols, and sphingolipids (Titz et al.
2016). Few studies have investigated the effect of
inhaled nanomaterials on the lung lipidome and to
date, all have been targeted. Gold nanoparticles (3-
week exposure) had no effect on total lung surfac-
tant, sphingolipids or glycerophospholipids, except
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a decrease in one PS species (Yu et al. 2007).
Single-walled carbon nanotubes (4-d exposure) pro-
duced no changes in total phospholipids, no oxi-
dized PC or PE species, but some oxidized minor
phospholipid species, suggesting selective rather
than nonspecific effects (Tyurina et al. 2011).
Recently, alterations in numerous phosphorylcho-
line-containing lipid species were identified in rat
lung following inhalation of ZnO particles (35 nm
and 250 nm), with the analysis suggesting that
these included lipids involved in membrane con-
formation and cellular signaling (Lee et al. 2016,
2018). In this study, untargeted mass spectrometry-
based lipidomics revealed that the most marked
effect of CeO2NP exposure is the significant increase
of some lipids within the category of glycerophos-
pholipids, dominated by PC and PE (Supplementary
Tables S3 & S4 and Supplementary File SI1).
Comparison of the putatively annotated lipids that
were perturbed, with information on individual lipid
species usually identified within the lung (Griese
et al. 2015; Titz et al. 2016; Zemski Berry et al.
2017), revealed that the majority of the perturbed
species were not those usually identified at signifi-
cant concentrations within the lung. Comparing the
annotated lipids against a comprehensive profile of
lung glycerophospholipids suggests that of the 80
lipids listed by Zemski Berry et al. (2017) only three
(PC(14:0/16:0), PC(16:0/16:1) and PE(16:0/18:1)) were
significantly modified by CeO2NP exposure. The
results of the global lipidomics analysis, the first to
be undertaken for an in vivo nanotoxicology inhal-
ation study, suggest minor changes to a small num-
ber of commonly found lipids within the lung, but
potentially more marked changes to less abundant
lipids, which may indicate effects for specific cells/
pathways. This could usefully be investigated fur-
ther using a targeted analysis of these putatively
annotated lipids.
Relevance of aerosol concentration and
characteristics
Cerium concentrations in ambient air in Newcastle
(UK) post-introduction of EnviroxTM to local bus
fleets were approximately 0.5 ng/m3 (Park et al.
2008a; Cassee et al. 2011; Gantt et al. 2015). A num-
ber of modeling studies have estimated potential
future concentrations based on the more extensive
use of the additives, including 1.25 103 ng/m3 (HEI
2001), 5–80 ng/m3 (Park et al. 2008a), and 22 ng/m3
(Erdakos et al. 2014). These concentrations are
lower than used in this study (1.8 106 ng/m3),
however, short-term exposures were used rather
than the chronic exposures that would arise in the
general population from the use of these fuel addi-
tives. Ma et al. (2011) estimated a lifetime lung bur-
den of 936mg/kg and Park et al. (2008a) estimated
a 20-year lung burden of 30 mg. The doses delivered
in our study were of this order, i.e. comparable to
estimated lifetime exposure levels.
Laboratory studies have found ceria particles
emitted from various engines using CeO2NP fuel
additives with a range of sizes, including: majority
<80 nm (Skillas et al. 2000); ca. 75 nm (Gantt et al.
2015); and typically 60–300 nm (Dale et al. 2017), all
broadly consistent with measurements made during
field studies (5–100 nm) (Gantt et al. 2014) and with
the size of the aerosol agglomerates used in this
study. It is important to note, however, that emitted
ceria particles are typically single crystals (or small
groups thereof) formed within the engine from the
smaller particles (8–10 nm) within the additive,
rather than agglomerates as used here. This may
impact on the resulting effects and could usefully
be investigated further, but in this context it is
important to note that studies using a range of
sizes of primary particles producing aerosol agglom-
erates of a similar size have found that the resulting
biological effects were very similar at concentrations
below overload (Gosens et al. 2014; Keller et al.
2014), suggesting that aerosol particle size, rather
than primary particle size, is a key factor driving
biological effects. It is also necessary to acknow-
ledge that in the environment some ceria particles
would be attached to larger micron-sized soot par-
ticles, which may also affect their biological effects,
although the importance of this is unclear with one
study indicating 40% of ceria particles associated
with larger soot particles (Gantt et al. 2015) but
another suggesting significantly lower levels (Skillas
et al. 2000).
Diesel emissions are complex mixtures of gases
and particles, and ultimately a complete assessment
of the overall impact of using CeO2NP fuel additives
on human health needs to consider all aspects of
the changes in the emission characteristics (Zhang
et al. 2013). Some studies have used diesel exhaust
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from machines using fuel additives. Cassee et al.
(2012) exposed atherosclerosis-prone mice to
exhaust from a diesel engine using standard fuel
(DE) or fuel containing CeO2NP (DECe) and found a
trend of increasing atherosclerotic plaques follow-
ing DE exposure that was not evident in the DCeE
group. Overall there were no clear pathological
changes in either group. These results contrast with
those of Snow et al. (2014), who exposed rats to
diesel exhaust (DE) from a generator run using die-
sel fuel, with (DECe) and without (DE) the addition
of CeO2NP and found that DECe induced greater
adverse pulmonary effects. Clearly such studies are
extremely useful in evaluating the overall effects of
the introduction of CeO2NP fuel additives, however,
the influence of engine type, engine abatement,
running conditions, and exhaust ageing may be sig-
nificant in determining the characteristics of the
output. Thus, studies investigating the biological
effects of relevant CeO2NPs remain of use in under-
standing their contribution to overall effects.
Conclusions
Short-term inhalation exposure to nano-sized cer-
ium oxide agglomerates induced a significant pul-
monary inflammatory effect with a limited
resolution by 7 d post-exposure, indicating the
potential for longer-term effects, which is worthy of
further investigation. Comparison with the results of
previous studies using larger aerosol particle sizes
supports a hypothesis that aerosol particle size is a
key toxicity driver and thus emphasizes the need
for future in vivo inhalation studies to use nanoma-
terial aerosol sizes of environmental relevance.
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